| Literature DB >> 35162676 |
Shogo Tsutsumi1, Noriaki Maeda1, Tsubasa Tashiro1, Satoshi Arima1, Rami Mizuta1, Kazuki Fukui1, Koichi Naito2, Makoto Komiya1, Yukio Urabe1.
Abstract
Vaccinations may be one of the solutions to end the COVID-19 pandemic. One's psychological state may be strongly related to one's willingness to be vaccinated. This study investigated the relationship between the psychological state of Japanese university students and their willingness to be vaccinated. A self-report questionnaire on COVID-19, its vaccines (vaccination status, and perceived efficacy and safety), and psychological state (anxiety and depressive mood) was administered online, and 560 valid responses were obtained. The unvaccinated group reported significantly lower perceived vaccine effectiveness and importance than the vaccinated group. However, there were no differences in anxiety and depressive mood symptoms between the two groups. Multivariate logistic regression analysis was performed on the unvaccinated participants to identify the factors associated with their unwillingness to be vaccinated; there was a significant association between anxiety and unwillingness to receive the vaccine (p < 0.05). However, there was no significant association between depressive mood and unwillingness to receive the vaccine. The results suggest that timely psychological support for Japanese university students experiencing high levels of anxiety is important in accelerating vaccination programs.Entities:
Keywords: COVID-19; Japan; coronavirus disease; psychological distress; university student; vaccine
Mesh:
Substances:
Year: 2022 PMID: 35162676 PMCID: PMC8835576 DOI: 10.3390/ijerph19031654
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart of participant recruitment.
Sociodemographic data, mental health status, and knowledge of and attitude toward COVID-19 among participants according to vaccination status.
| Variable | Total | Vaccinated Group | Unvaccinated Group ( | Effect Size | |
|---|---|---|---|---|---|
| Age | 21.4 ± 3.1 | 21.6 ± 3.4 | 21.0 ± 2.32 | 0.090 | |
| Gender | 0.427 b | 0.034 | |||
| Male | 218 (38.9%) | 148 (37.9%) | 70 (41.4%) | ||
| Female | 342 (61.1%) | 243 (62.1%) | 99 (58.6%) | ||
| Household structure | 0.621 b | 0.041 | |||
| Living alone | 264 (47.1%) | 185 (47.3%) | 79 (46.8%) | ||
| With others | 296 (52.9%) | 206 (52.7%) | 90 (53.2%) | ||
| Part-time job | 0.753 b | 0.013 | |||
| Employed | 406 (72.5%) | 285 (72.9%) | 121 (71.6%) | ||
| None | 154 (27.5%) | 106 (27.1%) | 48 (28.4%) | ||
| Movement restrictions | 0.504 b | 0.049 | |||
| Strict | 56 (10.0%) | 39 (10.0%) | 17 (10.1%) | ||
| Except for shopping or work | 444 (79.3%) | 314 (80.3%) | 130 (76.9%) | ||
| No | 60 (10.7%) | 38 (9.7%) | 22 (13.0%) | ||
| Fear of COVID-19 infection (Yes) | 464 (82.9%) | 325 (83.1%) | 139 (82.3%) | 0.802 b | 0.011 |
| Knowledge about the COVID-19 | |||||
| Can one be reinfected after | 535 (95.5%) | 375 (95.9%) | 160 (94.7%) | 0.517 b | 0.027 |
| Is there currently an | 413 (73.8%) | 300 (76.7%) | 113 (66.9%) |
| 0.103 |
| Importance of vaccination | |||||
| To protect self | 5.0 [4.0–5.0] | 5.0 [4.0–5.0] | 4.0 [3.0–5.0] |
| 0.326 |
| To protect others | 5.0 [4.0–5.0] | 5.0 [4.0–5.0] | 4.0 [4.0–5.0] |
| 0.224 |
| Anxiety symptoms (GAD-2 score ≥ 3) | 85 (15.2%) | 56 (14.3%) | 29 (17.2%) | 0.390 b | 0.036 |
| Depressive symptoms (PHQ-2 score ≥ 3) | 72 (12.9%) | 54 (13.8%) | 18 (10.7%) | 0.305 b | 0.043 |
Note. Statistically significant results are in bold. GAD-2, generalized anxiety disorder. PHQ-2, Patient Health Questionnaire. GAD-2 and PHQ-2 scores of ≥3 are considered a positive screening. Data are expressed as means ± SD, n (%), or medians (interquartile range). a Results of the Mann–Whitney U test. b Results of the chi-squared test.
Sociodemographic data, mental health status, and knowledge of and attitude toward COVID-19 among unvaccinated participants according to vaccination willingness.
| Unvaccinated Respondents ( | ||||
|---|---|---|---|---|
| Variable | Group A | Group B | Effect Size | |
| Age | 21.0 ± 0.20 | 21.1 ± 0.37 | 0.528 a | 0.049 |
| Gender | 0.874 b | 0.012 | ||
| Male | 53 (41.1%) | 17 (42.5%) | ||
| Female | 76 (58.9%) | 23 (57.5%) | ||
| Household structure | 0.507 b | 0.090 | ||
| Living alone | 59 (45.7%) | 20 (50.0%) | ||
| With others | 70 (54.3%) | 20 (50.0%) | ||
| Part-time job | 0.290 b | 0.081 | ||
| Employed | 95 (73.6%) | 26 (65.0%) | ||
| None | 34 (26.4%) | 14 (35.0%) | ||
| Movement restrictions | 0.485 b | 0.092 | ||
| Strict | 12 (9.3%) | 5 (12.5%) | ||
| Except for shopping or work | 102 (79.1 %) | 28 (70.0%) | ||
| No | 15 (11.6 %) | 7 (17.5%) | ||
| Fear of COVID-19 infection (Yes) | 109 (84.5 %) | 30(75.0%) | 0.170 b | 0.106 |
| Knowledge about the COVID-19 | ||||
| Can one be reinfected after | 124 (96.1%) | 36 (90.0%) | 0.132 b | 0.116 |
| Is there currently an | 95 (73.6%) | 18 (45.0%) |
| 0.259 |
| Importance of vaccination | ||||
| To protect self | 4.0 [4.0–5.0] | 3.0 [2.0–3.0] |
| 0.528 |
| To protect others | 5.0 [4.0–5.0] | 3.0 [3.0–4.0] |
| 0.536 |
| Anxiety symptoms (GAD-2 score ≥ 3) | 17 (13.2%) | 12 (30.2%) |
| 0.033 |
| Depression symptoms (PHQ-2 score ≥ 3) | 13 (10.1%) | 5 (12.5%) | 0.664 b | 0.190 |
Note: Group A refers to the group with the participants who were willing to receive the vaccine. Group B refers to the group with the participants who were unwilling to receive the vaccine. Statistically significant results are in bold. GAD-2, generalized anxiety disorder. PHQ-2, Patient Health Questionnaire. Data are expressed as means ± SD, n (%), or medians (interquartile range). a Results of the Mann–Whitney U test. b Results of the chi-squared test.
Logistic regression analysis for Model 2: association of the willingness to receive the vaccine with psychological distress assessment domains.
| Primary Outcome | Unadjusted a OR | Adjusted b OR | ||
|---|---|---|---|---|
| Anxiety symptoms (GAD-2 score ≥ 3) | 2.824 (1.210–6.587) |
| 3.157 (1.228–8.118) |
|
Statistically significant results are in bold. a Only anxiety symptoms (GAD-2 score ≥ 3) were considered for vaccination willingness. b Adjusted model adjusting for age, gender, and depressive symptoms (PHQ-2 score ≥ 3). GAD-2, generalized anxiety disorder. CI, confidence interval. Variance inflation factor: PHQ-2: 1.54; GAD-2: 1.54.